Has Jeffry Gerber, MD received payments from drug or device companies?

Yes. Drug and device makers reported $935 in general payments to Jeffry Gerber, MD across 50 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeffry Gerber, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeffry Gerber, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeffry Gerber, MD

Family Medicine · Littleton, CONPI 1316031529

Payments from drug & device makers

$935in general payments, 2019–2025

Across 50 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$797
Exact Sciences$48
Lilly USA, LLC$34
Vanda Pharmaceuticals Inc.$22
Currax Pharmaceuticals LLC$18
Cleerly, Inc.$17

What the payments were for

Food & beverage$935100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	43	$797
Exact Sciences	2	$48
Lilly USA, LLC	2	$34
Vanda Pharmaceuticals Inc.	1	$22
Currax Pharmaceuticals LLC	1	$18
Cleerly, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

FREESTYLE LIBRE 3$130

How this compares

$935 in reported general payments places this provider in the 80th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado →

Medicare billing

Part B allowed, 2024

$82,448

Medicare patients

206

Services billed

690

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MounjaroTirzepatide	71	$90,490
OzempicSemaglutide	36	$33,950
XareltoRivaroxaban	29	$30,102
EliquisApixaban	13	$23,209
Tresiba Flextouch U-100Insulin Degludec	23	$11,086
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	14	$2,421
Levothyroxine Sodium	173	$1,648
SynthroidLevothyroxine Sodium	23	$1,578
Omeprazole	66	$1,558
Albuterol Sulfate HfaAlbuterol Sulfate	27	$1,192
Oxybutynin Chloride ErOxybutynin Chloride	20	$1,181
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	13	$1,139
Rosuvastatin Calcium	118	$1,138
Lisinopril	154	$1,085
Gabapentin	63	$1,083

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Lilly USA, LLCMounjaro	$34	$90,49071 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Littleton

Frank RauziLittleton$168K
Julie JeffersLittleton$35K
Clint FlanaganDacono$7.6M
Larry OdekirkCastle Rock$6.3M
Ripley HollisterColorado Springs$5.5M
Timothy ColanderAurora$3.1M
Mia ScottDenver$993K
Matthew LewisAurora$960K
Ethan LazarusDenver$688K
Patrick BarryFraser$568K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →